PATENT CLAIM ANALYSIS

Application Number: 16083534
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "452000"]

Abstract:
The present invention relates to a binder tree pharmaceutical composition comprising canagliflozin or a prodrug or a pharmaceutically acceptable salt thereof, and one or more 5 pharmaceutically acceptable excipients, wherein the said composition is devoid of canagliflozin hemihydrate, and having acceptable chemical stability, polymorphic stability & comparative dissolution and bioequivalence profile to that of INVOKANA® tablets.

Claim (Index 5):
The binder free pharmaceutical composition of  claim 2 , wherein the disintegrant is croscarmellose sodium.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.38636
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15400005', '13446114', '12934296', '15115440', '15249082']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7066153294616907
- 35 USC 102 Novelty (BERT): 0.5122927374089976
- Combined Prediction Score: 0.6871830702564214
- Mean Citation Score: 201.611624
- Max Citation Score: 215.38701
- Similarity Product: 119.66049558917103

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test